Research Topic · Peer-Reviewed

Mycophenolic Acid

Mycophenolic acid (MPA) is an active metabolite of the anti-fungal drug mycophenolate mofetil, which is widely used for the prevention of organ rejection in transplant patients. MPA is an immunosuppressive agent, meaning that it can be used to reduce the activity of the immune system, which may help to prevent organ…

Curated from this journal's research 📚 1 peer-reviewed article cited Cited 7× across the literature 🗓 Reviewed June 2026

Overview

Mycophenolic acid (MPA) is an active metabolite of the anti-fungal drug mycophenolate mofetil, which is widely used for the prevention of organ rejection in transplant patients. MPA is an immunosuppressive agent, meaning that it can be used to reduce the activity of the immune system, which may help to prevent organ rejection. It is also used in the treatment of autoimmune diseases such as lupus, rheumatoid arthritis, and psoriasis. MPA works by blocking an enzyme involved in the production of essential proteins and lipids, which helps to reduce inflammation and improve symptoms of autoimmune disease. In addition, it has been studied for its potential to reduce the risk of certain cancers, such as colorectal cancer. Mycophenolic acid is an important active metabolite of mycophenolate mofetil and has significant implications for the treatment and prevention of immune-related disorders.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

How this research is being cited

The 1 article above has been cited 7 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Mycophenolic Acid, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Amino Acids.

Journal editorial board
Nicolas Inguimbert · France

This page summarises published research for orientation; it is not medical or professional advice.